The CAAs modulate, for instance, the behavior of breast cancer cells via the release of pro-inflammatory mediators such as IL-6, TNF-α, CCL2, or CCL5, promoting angiogenesis, proliferation, and metastasis [126,127,128]. This evidence concerns the gene CCL2 and breast cancer.